A dosimetric comparison of volumetric modulated arc therapy with step-and-shoot intensity modulated radiation therapy for prostate cancer

Practical Radiation Oncology

Volumn 5, Issue 1, 2015, Pages 11-15

  Mellon, Eric A ^a   Javedan, Khosrow ^a   Strom, Tobin J ^a   Moros, Eduardo G ^a   Biagioli, Matthew C ^a   Fernandez, Daniel C ^a   Wasserman, Stu G ^a   Wilder, Richard B ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL EVALUATION; COMPARATIVE EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOSIMETRY; HIGH RISK PATIENT; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERMEDIATE RISK PATIENT; MALE; PROSTATE CANCER; RADIATION BEAM; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIOTHERAPY; RADIOTHERAPY PLANNING SYSTEM; TARGET ORGAN; TISSUE DISTRIBUTION; TREATMENT PLANNING; TUMOR VOLUME; VERY ELDERLY; VOLUMETRIC MODULATED ARC THERAPY; COMPUTER ASSISTED RADIOTHERAPY; PROCEDURES; PROSTATIC NEOPLASMS; RADIOMETRY; RETROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; HUMANS; MALE; PROSTATIC NEOPLASMS; RADIOMETRY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES;

EID: 84920412284     PISSN: 18798500     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prro.2014.03.003     Document Type: Article

References (32)

1. Cancer Facts and Figures 2013. Atlanta: American Cancer Society Available at: Accessed October 31, 2013. http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-036845.pdf.
2. Viani G.A., Stefano E.J., Afonso S.L. Higher-than-conventional radiation doses in localized prostate cancer treatment: A meta-analysis of randomized, controlled trials. Int J Radiat Oncol Biol Phys 2009, 74:1405-1418.
3. Amin N., Konski A.A. Intensity-modulated radiation therapy for prostate cancer is cost effective and improves therapeutic ratio. Expert Rev Pharmacoecon Outcomes Res 2012, 12:447-450.
4. Dinan M.A., Robinson T.J., Zagar T.M., et al. Changes in initial treatment for prostate cancer among Medicare beneficiaries, 1999-2007. Int J Radiat Oncol Biol Phys 2012, 82:e781-e786.
5. Zelefsky M.J., Fuks Z., Happersett L., et al. Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother Oncol 2000, 55:241-249.
6. Davidson M.T., Blake S.J., Batchelar D.L., Cheung P., Mah K. Assessing the role of volumetric modulated arc therapy (VMAT) relative to IMRT and helical tomotherapy in the management of localized, locally advanced, and post-operative prostate cancer. Int J Radiat Oncol Biol Phys 2011, 80:1550-1558.
7. Fontenot J.D., King M.L., Johnson S.A., Wood C.G., Price M.J., Lo K.K. Single-arc volumetric-modulated arc therapy can provide dose distributions equivalent to fixed-beam intensity-modulated radiation therapy for prostatic irradiation with seminal vesicle and/or lymph node involvement. Br J Radiol 2012, 85:231-236.
8. Hall W.A., Fox T.H., Jiang X., et al. Treatment efficiency of volumetric modulated arc therapy in comparison with intensity-modulated radiotherapy in the treatment of prostate cancer. J Am Coll Radiol 2013, 10:128-134.
9. Shaffer R., Morris W.J., Moiseenko V., et al. Volumetric modulated arc therapy and conventional intensity-modulated radiotherapy for simultaneous maximal intraprostatic boost: A planning comparison study. Clin Oncol (R Coll Radiol) 2009, 21:401-407.
10. Tsai C.L., Wu J.K., Chao H.L., Tsai Y.C., Cheng J.C. Treatment and dosimetric advantages between VMAT, IMRT, and helical tomotherapy in prostate cancer. Med Dosim 2011, 36:264-271.
11. Wolff D., Stieler F., Welzel G., et al. Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer. Radiother Oncol 2009, 93:226-233.
12. Palma D., Vollans E., James K., et al. Volumetric modulated arc therapy for delivery of prostate radiotherapy: Comparison with intensity-modulated radiotherapy and three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 2008, 72:996-1001.
13. Hall W.A., Colbert L., Nickleach D., et al. Reduced acute toxicity associated with the use of volumetric modulated arc therapy for the treatment of adenocarcinoma of the prostate. Pract Radiat Oncol 2013, 3:e157-e164.
14. Kopp R.W., Duff M., Catalfamo F., Shah D., Rajecki M., Ahmad K. VMAT vs. 7-field-IMRT: Assessing the dosimetric parameters of prostate cancer treatment with a 292-patient sample. Med Dosim 2011, 36:365-372.
15. Dearnaley D.P., Sydes M.R., Graham J.D., et al. Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: First results from the MRC RT01 randomised controlled trial. Lancet Oncol 2007, 8:475-487.
16. Kuban D.A., Levy L.B., Cheung M.R., et al. Long-term failure patterns and survival in a randomized dose-escalation trial for prostate cancer. Who dies of disease?. Int J Radiat Oncol Biol Phys 2011, 79:1310-1317.
17. Peeters S.T., Heemsbergen W.D., Koper P.C., et al. Dose-response in radiotherapy for localized prostate cancer: Results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J Clin Oncol 2006, 24:1990-1996.
18. Zietman A.L., DeSilvio M.L., Slater J.D., et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled trial. JAMA 2005, 294:1233-1239.
19. Deutsch I., Zelefsky M.J., Zhang Z., et al. Comparison of PSA relapse-free survival in patients treated with ultra-high-dose IMRT versus combination HDR brachytherapy and IMRT. Brachytherapy 2010, 9:313-318.
20. Hoskin P.J., Motohashi K., Bownes P., Bryant L., Ostler P. High dose rate brachytherapy in combination with external beam radiotherapy in the radical treatment of prostate cancer: Initial results of a randomised phase three trial. Radiother Oncol 2007, 84:114-120.
21. Martinez A.A., Gonzalez J., Ye H., et al. Dose escalation improves cancer-related events at 10 years for intermediate- and high-risk prostate cancer patients treated with hypofractionated high-dose-rate boost and external beam radiotherapy. Int J Radiat Oncol Biol Phys 2011, 79:363-370.
22. Sathya J.R., Davis I.R., Julian J.A., et al. Randomized trial comparing iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate. J Clin Oncol 2005, 23:1192-1199.
23. Pommier P., Chabaud S., Lagrange J.L., et al. Is there a role for pelvic irradiation in localized prostate adenocarcinoma? Preliminary results of GETUG-01. J Clin Oncol 2007, 25:5366-5373.
24. Roach M., DeSilvio M., Thomas C.R., et al. Progression free survival (PFS) after whole-pelvic (WP) vs. mini-pelvic (MP) or prostate only (PO) radiotherapy (RT): A subset analysis of RTOG 9413, a Phase III prospective randomized trial using neoadjuvant and concurrent (N&CHT). Int J Radiat Oncol Biol Phys 2004, 60:S264-S265.
25. Paddick I. A simple scoring ratio to index the conformity of radiosurgical treatment plans. Technical note. J Neurosurg 2000, 93(Suppl. 3):219-222.
26. Adamson J., Wu Q. Prostate intrafraction motion assessed by simultaneous kilovoltage fluoroscopy at megavoltage delivery I: Clinical observations and pattern analysis. Int J Radiat Oncol Biol Phys 2010, 78:1563-1570.
27. Reggiori G., Mancosu P., Tozzi A., et al. Cone beam CT pre- and post-daily treatment for assessing geometrical and dosimetric intrafraction variability during radiotherapy of prostate cancer. J Appl Clin Med Phys 2011, 12:3371.
28. Fontenot J.D., Lee A.K., Newhauser W.D. Risk of secondary malignant neoplasms from proton therapy and intensity-modulated x-ray therapy for early-stage prostate cancer. Int J Radiat Oncol Biol Phys 2009, 74:616-622.
29. Hall E.J. Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys 2006, 65:1-7.
30. Murray L., Henry A., Hoskin P., et al. Second primary cancers after radiation for prostate cancer: A review of data from planning studies. Radiat Oncol 2013, 8:172.
31. Van Gestel D., van Vliet-Vroegindeweij C., Van den Heuvel F., et al. SmartArc and TomoHD compared with classical step and shoot and sliding window intensity modulated radiotherapy in an oropharyngeal cancer treatment plan comparison. Radiat Oncol 2013, 8:37.
32. Rule W., Jiang L., Boike T., et al. A dosimetric comparison of prostate plans: IMRT, SmartArc, RapidArc and HybridAr. Int J Radiat Oncol Biol Phys 2010, 78:S847.